ACTRN12621000104853
Completed
Phase 3
A randomised double-blind placebo-controlled study to evaluate the effect ofcurcumin on BDNF levels in otherwise healthy adults.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Brain-Derived Neurotrophic Factor in healthy adults
- Sponsor
- RDC Global Pty Ltd
- Enrollment
- 69
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male and females aged 18\-40 years old
- •Able to provide informed consent
- •Agree not to take other supplements (e.g. curcumin, iron, resveratrol, fish oil) that may affect BDNF for the duration of the trial and within 2 weeks prior to commencing the study
Exclusion Criteria
- •Iron deficient anaemia
- •Unstable or serious illness (e.g. kidney, liver, biliary, GIT, heart conditions, diabetes, thyroid gland function, malignancy, lung conditions, chronic asthma, mood disorders or neurological disorders such as MS)\*
- •Currently taking medications that may affect BDNF such as antidepressants or anxiety medications, or have taken within the previous 6 months
- •Prescribed/receiving anticoagulation therapy (e.g., coumadin, heparin)
- •Females who are either trying to conceive, pregnant or lactating
- •Any chronic menstrual disorders or menopausal changes
- •Alcohol consumption exceeding 21 drinks/week
- •Active smoker/e\-cigarettes/nicotine use, use recreational drugs
- •Any chronic gastrointestinal problems
- •History of eating disorders
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised double-blind placebo-controlled study of energy, protein and micronutrients supplementation of elderly patients in active rehabilitation settingsutritional status in the elderlyNutritional, Metabolic, EndocrineNutritional statusISRCTN01133608The Health Foundation (UK)445
Completed
Not Applicable
A randomised double-blind placebo-controlled study to investigate the possible role of Opiate Morphine (MST) in the treatment of chronic cough.ISRCTN18474014Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)30
Completed
Not Applicable
A randomised double-blind placebo controlled study of adenosine given as a Bier's block for patients with neuropathic pain in the limbsSigns and Symptoms: PainSigns and SymptomsPainISRCTN86618747Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)30
Not yet recruiting
Phase 1
Effect PartySmart Variants in alcohol subjects.CTRI/2021/03/032236The Himalaya Drug Company
Completed
Phase 2
A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libidoow libido in post menopausal women suffering from low serum testosteroneLow libido in post menopausal women suffering from low serum testosteroneReproductive Health and Childbirth - Menstruation and menopauseACTRN12605000481673FemPharm Pty Ltd and/or Acrux DDS Pty Ltd200